Traws Pharma, Inc. - Common Stock (TRAW)
1.6500
+0.1700 (11.49%)
NASDAQ · Last Trade: Jun 7th, 6:00 PM EDT

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 3, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 3, 2025

Via Benzinga · June 3, 2025

Traws Pharma just reported results for the second quarter of 2024.
Via InvestorPlace · August 16, 2024

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via Chartmill · June 3, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · June 3, 2025

Via Benzinga · June 3, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 3, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 13, 2025

Via Benzinga · January 16, 2025

Via Benzinga · January 13, 2025

Via Benzinga · December 30, 2024

Via Benzinga · December 30, 2024

Via Benzinga · December 24, 2024

Via Benzinga · December 23, 2024

Via Benzinga · December 23, 2024

Traws Pharma (NASDAQ: TRAW) shares soar as company reports positive results for single-dose treatment of H5N1 bird flu. No adverse events reported.
Via Benzinga · December 23, 2024

Via Benzinga · November 18, 2024

Via Benzinga · September 30, 2024